Equity Funding Review...Breaking News After the Closing Bell Friday on KWBT
CITY OF INDUSTRY, CA –July 15, 2004— Kiwa Bio-Tech Products Group Corporation, (OTC.BB: KWBT) announced today that it has received a $10 million financial commitment from Cornell Capital Partners, LP.
This is the REAL DEAL. Cornell Capital has funded some very successful companies in the past.
As of June 2004, the Cornell group has made available in excess of $800 million for over 100 publicly traded corporations, including and listed on the NSADAQ, AMEX, and OTCBB markets. Since 2001, they are the most active investor in structured private placements, globally; and by the end of 2002 were ranked #1 both in "all PIPE" and "structured PIPE" transactions with 33 and 32 transactions, respectively. Here are just a few of Cornell's success stories:
Reliv International (NASDAQ: RELV)
On Feb. 26, 2!
004 it was announced that RELV was to receive $5 million in funding. Stock Price on Feb. 26 was $6.38. RELV peaked at $11.50 on 20 May, 2004. RELV, based in St. Louis, manufactures and distributes several lines of food products, including nutritional and fiber supplements, diet management products, functional foods and sports drink mixes.
NeoMedia Technologies (OTC.BB: NEOM)
NEOM received a $10 million equity line of credit from Cornell Capital in Feb. 2003. Stock price at that time of financing was $0.02. In Sept. 2003, NEOM peaked at $0.28. NEOM is an international leader in print-to-internet technology.
CTI Industries Corporation (NASDAQ: CTIB)
CTIB just got their financing wheels in motion. CTIB announced on 7 July, 2004 that it had entered into a Standby Equity Distribution Agreement ("SEDA") with Cornell Capital for $5 million. CTIB went from $2.20 on 8 July to 2.72 on 9 July.
As you can see, where Cornell Capital's
Equity Funding Review (EFR) is not a registered financial advisory. The information presented by EFR is not for purchasing or selling securities. EFR compiles then distributes opinions, comments and information based on other public sources. Penny stocks are considered to be highly speculative and may be unsuitable for all but very aggressive investors. EFR does not hold nor does it plan to hold a position in this stock. This Profile was a paid advertisement by a third party not affiliated with the profiled company. EFR was compensated two thousand dollars to publish and distribute this report. Paid advertisements for a third party do not necessarily reflect the views of EFR. Target prices may fluctuate depending on market environments. Please always consult a registered financial advisor before making any decisions. This report is for entertainment and advertising purposes only and should not be used as investment advice. EFR, Apart! ado 261-4005 Belen, Heredia, Costa Rica
Subscribe HERE
No more ads, vivianaheningeryjay@1net.gr
caine
cacti
contusion
blithe
gneiss
huntsville
stolid
barbarian